Variable | Control (N = 67*) | Intervention (N = 94*) |
---|---|---|
Age | 81 (12) | 83 (12) |
Sex (Female) | 43 (64.2%) | 65 (69.1%) |
Charlson co-morbidities | Â | Â |
Alzheimer's/Dementia | 38 (56.7%) | 62 (66.0%) |
Diabetes | 22 (32.8%) | 36 (38.3%) |
Stroke/TIA | 20 (29.9%) | 29 (30.9%) |
Diabetes with end organ damage | 10 (14.9%) | 22 (23.4%) |
Paraplegia/Hemiplegia | 11 (16.4%) | 15 (16.0%) |
Any solid tumour | 6 (9.0%) | 16 (17.0%) |
COPD | 10 (14.9%) | 7 (7.4%) |
Congestive Heart Failure | 4 (6.0%) | 11 (11.7%) |
Peripheral Vascular Disease | 5 (7.5%) | 6 (6.4%) |
Myocardial Infarction | 3 (4.5%) | 6 (6.4%) |
Moderate or severe renal disease | 1 (1.5%) | 4 (4.3%) |
Charlson Co-morbidity Index | 3 (2) | 3 (2) |
Other co-morbidities | Â | Â |
Hypertension | 37 (55.2%) | 55 (58.5%) |
Osteoarthritis | 36 (53.7%) | 42 (44.7%) |
Osteoporosis | 23 (34.3%) | 33 (35.1%%) |
Coronary Artery Disease | 15 (22.4%) | 18 (19.1%) |
Parkinson's disease | 7 (10.4%%) | 9 (9.6%) |
Contractures | 5 (7.5%) | 6 (6.4%%) |
Spasticity | 4 (6.0%) | 5 (5.3%) |
PU Risk factors | Â | Â |
Incontinence (urine) | 66 (98.5%) | 91 (96.8%) |
Incontinence (stool) | 58 (86.6%) | 79 (84.0%) |
Bedbound | 49 (81.7%%) | 71 (87.7%) |
Mental Status (Not alert/not oriented) | 52 (77.6%) | 78 (83.0%) |
Nutritional supplement | 55 (82.1%) | 80 (85.1%) |
Tube Feed | 5 (7.5%) | 7 (7.4%) |
Body Mass Index | 25 (8) | 24 (6) |